Journal of Neuroscience Research · 2006 · 126 citations · 71 references
Life SciencesCell BiologyDevelopmental BiologyCell DifferentiationGene ExpressionStem Cell BiologyGlial Cell DifferentiationMesodermal DifferentiationNeural Stem Cell BiologyNeural Stem CellsNeurogenesisBone Marrow - Derived CellsBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsGlial-to-neuronal ConversionMarker Gene ExpressionNeural Cell DifferentiationNeural Stem Cell EpigeneticsNeural Stem Cell Markers
Human adult bone marrow-derived mesodermal stromal cells (hMSCs) are able to differentiate into multiple mesodermal tissues, including bone and cartilage. There is evidence that these cells are able to break germ layer commitment and differentiate into cells expressing neuroectodermal properties. There is still debate about whether this results from cell fusion, aberrant marker gene expression or real neuroectodermal differentiation. Here we extend our work on neuroectodermal conversion of adult hMSCs in vitro by evaluating various epigenetic conversion protocols using quantitative RT-PCR and immunocytochemistry. Undifferentiated hMSCs expressed high levels of fibronectin as well as several neuroectodermal genes commonly used to characterize neural cell types, such as nestin, beta-tubulin III, and GFAP, suggesting that hMSCs retain the ability to differentiate into neuroectodermal cell types. Protocols using a direct differentiation of hMSCs into a neural phenotype failed to induce significant changes in morphology and/or expression of markers of early and mature glial/neuronal cells types. In contrast, a multistep protocol with conversion of hMSCs into a neural stem cell-like population and subsequent terminal differentiation in mature glia and neurons generated relevant morphological changes as well as significant increase of expression levels of marker genes for early and late neural cell types, such as nestin, neurogenin2, MBP, and MAP2ab, accompanied by a loss of their mesenchymal properties. Our data provide an impetus for differentiating hMSCs in vitro into mature neuroectodermal cells. Neuroectodermally converted hMSCs may therefore ultimately help in treating acute and chronic neurodegenerative diseases. Analysis of marker gene expression for characterization of neural cells derived from MSCs has to take into account that several early and late neuroectodermal genes are already expressed in undifferentiated MSCs.
71
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Takayuki Asahara, Toyoaki Murohara, Alison Sullivan et al. · Science · 1997 · 8.7K citations
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Yuehua Jiang, Balkrishna Jahagirdar, R. Lee Reinhardt et al. · Nature · 2002 · 5.5K citations
Bone marrow cells regenerate infarcted myocardium
Donald Orlic, Jan Kajstura, Stefano Chimenti et al. · Nature · 2001 · 5.2K citations
CNS stem cells express a new class of intermediate filament protein
Urban Lendahl, Lyle B. Zimmerman, Ronald D.G. McKay · Cell · 1990 · 3.2K citations
Muscle Regeneration by Bone Marrow-Derived Myogenic Progenitors
Giuliana Ferrari, Maria Gabriella Cusella De Angelis, De Angelis et al. · Science · 1998 · 2.7K citations · Full text